A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Recruiting · Phase 3 · NCT05164172
Conditions: Migraine
At a glance
- Research payments reported, 2025
- $579,482
- U.S. investigators named
- 20
- Sites paid
- 19
- Planned or actual enrollment
- 600
About the trial
- Sponsor
- H. Lundbeck A/S
- Tested
- Eptinezumab (drug)
- Dates
- Started 2021-12-01; completion 2028-04-30
- Results posted
- Not yet
The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.
From ClinicalTrials.gov, last updated 2026-10-14. Full record, eligibility and contacts (opens in a new tab)
Industry funding
H. Lundbeck A S reported $579,482 in research payments for this study in 2025 (121 payments).
Products named: Vyepti
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Cristian Ionita, MD Child Neurology · Hartford, CT
- Kathleen B. Mullin, M.D. Neurology · Stamford, CT
- Stewart J. Tepper, M.D. Neurology · Stamford, CT
- Dario D. Altamirano, DO Family Medicine · Hialeah, FL
- Janice Y. Maldonado, MD Neurology · Tampa, FL
- Weldon A. Mauney III, M.D. Child Neurology · Gulf Breeze, FL
- James B. Renfroe, MD Child Neurology · Gulf Breeze, FL
- Sharoon Qaiser, M.D. Child Neurology · Lexington, KY
- Jack Gladstein, MD Child Neurology · Baltimore, MD
- Steven T. Deroos, MD Child Neurology · Grand Rapids, MI
- Suad Khalil, M.D. Child Neurology · East Lansing, MI
- Joel R. Saper, M.D. Pain Medicine · Ann Arbor, MI
- Robert A. Nahouraii, MD Child Neurology · Matthews, NC
- Warren D. Spinner, D.O. Neurology · Port Jefferson Station, NY
- Andrew D. Hershey, M.D. Child Neurology · Cincinnati, OH
- Maria Cristina C. Victorio, M.D. Neurology · Akron, OH
- Jerry J. Tomasovic, MD Child Neurology · San Antonio, TX
- Ryan P. Williams, MD Child Neurology · Norfolk, VA
- Lileth Joy Mondok, MD Child Neurology · Milwaukee, WI
- Jorge I. Lopez, MD Child Neurology · Huntington, WV
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Northwest Florida Clinical Res $134,260
- Neostart Corporation DBA Aga C $104,502
- Multicare Neuroscience $56,088
- The University of South Florida $45,472
- Yale University $34,275
- University of Kentucky Hospital, KY $32,194
- Spectrum Health System $28,068
- Akron Children's Hospital, OH $27,996
- Medical College of Wisconsin $24,880
- Road Runner Research LTD $21,247
- Cincinnati Childrens Hospital $18,772
- Jefferson Health $12,516
- Onsite Clinical Solutions LLC $9,413
- Michigan Headache and Neurological Institute $7,870
- Childrens Specialty Group PLLC $6,867
- Michigan State University $5,349
- University of Maryland Baltimore $3,900
- University Physicians & Surgeo $3,064
- New England Institute for Clinical Research $2,747
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.